We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
To drive the development of advanced therapies, industry is asking the European Medicines Agency to provide further guidance, harmonize EU regulations and exercise flexibility. Read More
Vermont Gov. Peter Shumlin signed into law Friday a transparency bill that would require certain drugmakers to justify their price increases for specific products. Read More